Hantech Bio-Technology Co (ROCO:1294) Interest Coverage: 76.36 (As of Jun. 2026) — 95% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1294 Hantech Bio-Technology Co Ltd ROCO:1294
72 GF Score
Price NT$51.50
GF Value NT$74.58
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Hantech Bio-Technology Co Interest Coverage?

Hantech Bio-Technology Co ROCO:1294 72 Interest Coverage is 76.36 as of Jun. 2026, which is 95% above its 10-year median of 39.07. GuruFocus rates ROCO:1294 with a GF Score™ of 72/100 and a GF Value™ of NT$74.58 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 1,504 Consumer Packaged Goods companies, Hantech Bio-Technology Co ranks better than 81.78% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Hantech Bio-Technology Co's Operating Income for the three months ended in Jun. 2026 was NT$46.5 Mil. Hantech Bio-Technology Co's Interest Expense for the three months ended in Jun. 2026 was NT$0.0 Mil. Hantech Bio-Technology Co's interest coverage for the quarter that ended in Jun. 2026 was 76.36. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Hantech Bio-Technology Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Hantech Bio-Technology Co's Interest Coverage or its related term are showing as below:

ROCO:1294' s Interest Coverage Range Over the Past 10 Years
Min: 17.15   Med: 39.07   Max: 87.5
Current: 70.3


ROCO:1294's Interest Coverage is ranked better than
81.78% of 1504 companies
in the Consumer Packaged Goods industry
Industry Median: 8.69 vs ROCO:1294: 70.30

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Hantech Bio-Technology Co  (ROCO:1294) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Hantech Bio-Technology Co Interest Coverage Related Terms


Hantech Bio-Technology Co Interest Coverage Historical Data

* Premium members only.

The historical data trend for Hantech Bio-Technology Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Hantech Bio-Technology Co Interest Coverage Chart

Hantech Bio-Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
29.62 113.30 224.07 36.73 58.11

Hantech Bio-Technology Co Quarterly Data
Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.88 53.06 68.41 85.53 76.36

ROCO:1294 vs KHC, GIS: Interest Coverage Comparison

For the Packaged Foods subindustry, Hantech Bio-Technology Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hantech Bio-Technology Co Interest Coverage vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Hantech Bio-Technology Co's Interest Coverage falls into.


ROCO:1294
72GF Score
Hantech Bio-Technology Co Ltd ROCO:1294
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hantech Bio-Technology Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hantech Bio-Technology Co's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, Hantech Bio-Technology Co's Interest Expense was NT$0.0 Mil. Its Operating Income was NT$173.0 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$83.2 Mil.

GuruFocus does not calculate Hantech Bio-Technology Co's interest coverage with the available data.

Hantech Bio-Technology Co's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Here, for the three months ended in Jun. 2026, Hantech Bio-Technology Co's Interest Expense was NT$0.0 Mil. Its Operating Income was NT$46.5 Mil. And its Long-Term Debt & Capital Lease Obligation was NT$84.1 Mil.

GuruFocus does not calculate Hantech Bio-Technology Co's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 76.36 mean?
Hantech Bio-Technology Co (ROCO:1294) has a Interest Coverage of 76.36 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hantech Bio-Technology Co and its competitors. This is 95% above median its historical median of 39.07. Over the past decade, Hantech Bio-Technology Co's Interest Coverage has ranged from 17.15 to 87.50. According to the industry distribution chart, Hantech Bio-Technology Co ranks #274 out of 1504 companies in the Consumer Packaged Goods industry, placing it in the top 18.2%.
Is Hantech Bio-Technology Co's Interest Coverage too high?
Hantech Bio-Technology Co's current Interest Coverage of 76.36 is 95% above median its 10-year median of 39.07. Over the past 10 years, this metric has ranged from a low of 17.15 to a high of 87.50. The Consumer Packaged Goods industry median Interest Coverage is 8.69. Hantech Bio-Technology Co's value of 76.36 is 778.7% above this industry median. Based on the distribution chart, Hantech Bio-Technology Co ranks #274 out of 1504 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Hantech Bio-Technology Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hantech Bio-Technology Co's Interest Coverage compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hantech Bio-Technology Co ranks #274 out of 1504 companies for Interest Coverage. This places Hantech Bio-Technology Co in the top 18% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 8.69. Hantech Bio-Technology Co's value of 76.36 is 778.7% above this benchmark. Historically, Hantech Bio-Technology Co's own Interest Coverage has ranged from 17.15 to 87.50 over the past decade. While the company's 10-year median is 39.07 vs. the industry median of 8.69, Hantech Bio-Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.69, based on 1,504 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hantech Bio-Technology Co's current Interest Coverage of 76.36 is 778.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Hantech Bio-Technology Co and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hantech Bio-Technology Co's current Interest Coverage is 76.36, which is 95% above median its own 10-year median of 39.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hantech Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Hantech Bio-Technology Co (ROCO:1294) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$74.58, compared to a current price of NT$51.50 — trading 30.9% below its estimated fair value. The current Interest Coverage is 76.36, which is 95% above median its 10-year median of 39.07 and 778.7% above the Consumer Packaged Goods industry median of 8.69. Hantech Bio-Technology Co's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Hantech Bio-Technology Co (ROCO:1294), the current Interest Coverage is 76.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hantech Bio-Technology Co (ROCO:1294) Overvalued in 2026?

Based on GuruFocus' analysis, Hantech Bio-Technology Co stock appears to be undervalued. The current stock price of NT$51.50 is trading 30.9% below its estimated GF Value™ of NT$74.58. GuruFocus considers Hantech Bio-Technology Co to be Significantly Undervalued.

Key valuation signals for ROCO:1294:

  • Interest Coverage: 76.36 (95% above median its 10-year median of 39.07)
  • GF Value™: NT$74.58 vs. price of NT$51.50 (30.9% below fair value)
  • GF Score™: 72/100 with 4 warning signs
  • Industry Position: 778.7% above the Consumer Packaged Goods median (#274 of 1504)

No single metric tells the full story. See the ROCO:1294 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hantech Bio-Technology Co Business Description

Address No. 101, Gongye Road, Xihu Township, Changhua, TWN, 514
Hantech Bio-Technology Co Ltd mainly engaged in the manufacture, trading, and agency of biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products.
72GF Score

Get the complete analysis for ROCO:1294

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$51.50
Price
NT$74.58
GF Value